TIGIT limits immune pathology during viral infections
TIGIT is a lymphocyte co-inhibitory receptor that can limit type 1 and cytotoxic T cell responses and maintain immunological tolerance. Here the authors show that TIGIT also limits immune pathology during LCMV or influenza infections in mice by driving IL-10 expression without negatively affecting t...
Guardado en:
Autores principales: | Michelle Schorer, Nikolas Rakebrandt, Katharina Lambert, Annika Hunziker, Katharina Pallmer, Annette Oxenius, Anja Kipar, Silke Stertz, Nicole Joller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8492053acd54e879e004b10fac09bc3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rapid expansion of Treg cells protects from collateral colitis following a viral trigger
por: Michelle Schorer, et al.
Publicado: (2020) -
TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
por: Paloma Riquelme, et al.
Publicado: (2018) -
Asymmetric cell division shapes naive and virtual memory T-cell immunity during ageing
por: Mariana Borsa, et al.
Publicado: (2021) -
Implication of TIGIT+ human memory B cells in immune regulation
por: Md Mahmudul Hasan, et al.
Publicado: (2021) -
A novel scoring system for TIGIT expression in classic Hodgkin lymphoma
por: Ombretta Annibali, et al.
Publicado: (2021)